Proteome-wide Mendelian randomization identifies causal plasma proteins in frontotemporal dementia.

Authors

Yuan Yao, Qin Zou, Ke Chen

Published in

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. Volume 47. Issue 8. Jul 25, 2026. Epub Jul 25, 2026.

Abstract

Frontotemporal dementia (FTD) is a genetically and clinically heterogeneous neurodegenerative disorder with no disease-modifying treatments. Plasma proteomic signatures offer a promising avenue for uncovering disease mechanisms and developing targeted interventions.
We conducted protein-wide Mendelian randomization meta-analysis to explore causal relationships between plasma proteins and FTD and four subtypes, utilizing comprehensive datasets of protein quantitative trait loci.
We identified four plasma proteins significantly associated with FTD, namely RGS7 and ASAP2 (increased risk), as well as TMCC3 and VPS29 (decreased risk). Subtype-specific analyses revealed distinct protein signatures, including S100A13 and TREM1 in behavioral variant FTD, ING4 and TEX29 in FTD overlapping with motor neuron disease, SPINT2 in progressive non-fluent aphasia, and UGDH in semantic dementia.
This study implicates specific plasma proteins in FTD pathogenesis, with subtype-dependent effects. The identified proteins represent potential biomarkers for stratification and therapeutic targets.

PMID:
42498838
Bibliographic data and abstract were imported from PubMed on 25 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.